Abstract: The present invention provides a tool for analysis of expression of Macaca fascicularis gene expression analysis tool containing a set of nucleic acids containing base sequences the same or substantially the same as two or more base sequences selected from the group consisting of the base sequences shown by SEQ ID NOs:1-14, or partial sequences thereof, and a method of analyzing the expression of Macaca fascicularis gene, including measuring a gene transcription product in a Macaca fascicularis sample using the tool.

Abstract: The present invention provides a tool for analysis of expression of Macaca fascicularis gene. The present invention provides a Macaca fascicularis gene expression analysis tool containing a set of nucleic acids containing base sequences the same or substantially the same as two or more base sequences selected from the group consisting of the base sequences shown by SEQ ID NOs: 1-14, or partial sequences thereof, and a method of analyzing the expression of Macaca fascicularis gene, including measuring a gene transcription product in a Macaca fascicularis sample using the tool.

Abstract: The present invention aims at providing a useful and novel G protein-coupled receptor protein and DNA thereof. The G protein-coupled receptor protein of the present invention and the like, and the polynucleotides encoding the receptor protein and the like, are useful for; 1) determination of ligands (agonists); 2) preparation of antibodies and antisera; 3) construction of recombinant receptor protein expression systems; 4) development of the receptor binding assay systems using the expression systems and screening of pharmaceutical candidate compounds; 5) effecting drug design based on comparison with structurally similar ligand receptors; 6) reagents for preparation of probes and PCR primers for gene diagnosis; 7) production of transgenic animals; and 8) pharmaceutical drugs for the gene prophylaxis and gene therapy.

Abstract: The present invention provides a human-derived protein or a salt thereof, a DNA encoding the same, a method for determination of ligand to the protein, a screening method/kits for a compound or its salt that alters a binding property between ligand and the protein, and the like. The human-derived protein or a DNA encoding the same of the present invention can be used in (1) determination of ligand to the protein of the present invention, (2) a prophylactic/therapeutic agent for diseases associated with dysfunction of the protein of the present invention, (3) a screening of a compound (agonist, antagonist, etc.) that alters a binding property between the protein and the ligand of the present invention, and the like.

Abstract: The present invention provides a human-derived protein or a salt thereof, a DNA encoding the same, a method for determination of ligand to the protein, a screening method/kits for a compound or its salt that alters a binding property between ligand and the protein, and the like. The human-derived protein or a DNA encoding the same of the present invention can be used in (1) determination of ligand to the protein of the present invention, (2) a prophylactic/therapeutic agent for diseases associated with dysfunction of the protein of the present invention, (3) a screening of a compound (agonist, antagonist, etc.) that alters a binding property between the protein and the ligand of the present invention, and the like.

Abstract: The present invention provides a novel G protein-coupled receptor comprising the same or substantially the same amino acid sequence as that represented by SEQ ID NO: 1, or a salt thereof, and a polynucleotide encoding the same. The present invention also provides their use such as pharmaceuticals, etc.

Abstract: The present invention aims at providing a useful and novel G protein-coupled receptor protein and DNA thereof.

Abstract: The present invention provides a novel G protein-coupled receptor comprising the same or substantially the same amino acid sequence as that represented by SEQ ID NO: 1, or a salt thereof, and a polynucleotide encoding the same. The present invention also provides their use such as pharmaceuticals, etc.

Abstract: The present invention provides a human-derived protein or a salt thereof, a DNA encoding the same, a method for determination of ligand to the protein, a screening method/kits for a compound or its salt that alters a binding property between ligand and the protein, and the like. The human-derived protein or a DNA encoding the same of the present invention can be used in (1) determination of ligand to the protein of the present invention, (2) a prophylactic/therapeutic agent for diseases associated with dysfunction of the protein of the present invention, (3) a screening of a compound (agonist, antagonist, etc.) that alters a binding property between the protein and the ligand of the present invention, and the like.

Abstract: The present invention provides a human-derived protein or a salt thereof, a DNA encoding the same, a method for determination of ligand to the protein, a screening method/kits for a compound or its salt that alters a binding property between ligand and the protein, and the like. The human-derived protein or a DNA encoding the same of the present invention can be used in (1) determination of ligand to the protein of the present invention, (2) a prophylactic/therapeutic agent for diseases associated with dysfunction of the protein of the present invention, (3) a screening of a compound (agonist, antagonist, etc.) that alters a binding property between the protein and the ligand of the present invention, and the like.

Abstract: The present invention aims at providing a useful and novel G protein-coupled receptor protein and DNA thereof.

Abstract: The present invention intends to screen a novel G protein-coupled receptor protein and to elucidate its function.

Abstract: The present invention intends to provide a novel protein useful for a screening of agonist/antagonist, and the like. Specifically, the present invention provides a novel protein or its salt, a DNA encoding the protein, a determination method of ligand for the protein, a screening method/kit for a compound that alters a binding property between a ligand and the protein, a compound obtained from the screening or its salt, and the like.

Abstract: The present invention provides a human-derived protein or a salt thereof, a DNA encoding the same, a method for determination of ligand to the protein, a screening method/kits for a compound or its salt that alters a binding property between ligand and the protein, and the like. The human-derived protein or a DNA encoding the same of the present invention can be used in (1) determination of ligand to the protein of the present invention, (2) a prophylactic/therapeutic agent for diseases associated with dysfunction of the protein of the present invention, (3) a screening of a compound (agonist, antagonist, etc.) that alters a binding property between the protein and the ligand of the present invention, and the like.

Abstract: The present invention provides a novel G protein-coupled receptor protein comprising the same or substantially the same amino acid sequence as that represented by SEQ ID NO: 5 or salts thereof, and a polynucleotide encoding the same. The present invention also provides a use such as pharmaceuticals, etc.

Abstract: The present invention provides a novel G protein-coupled receptor protein comprising the same or substantially the same amino acid sequence as that represented by SEQ ID NO: 1 or salts thereof, and a polynucleotide encoding the same. The present invention also provides a use such as pharmaceuticals, etc.

Abstract: The present invention aims at screening of a novel G protein-coupled receptor protein and elucidation of its function.

Abstract: A method of producing a catalyst for converting hydrocarbons involves spray-drying a slurry containing crystalline aluminosilicate zeolite and magnesium silicate mineral. The magnesium silicate mineral functioning as a metal trap contains 10 to 60 wt % of magnesium as an oxide. The magnesium silicate mineral has been treated with a phosphorus-containing solution.

Abstract: A novel foaming agent in dentifrice compositions, e.g., tooth pastes, is proposed which is an at least partially, with a basic compound, neutralized salt of a glycerin diester compound represented by the general formulaR.sup.1 --CO--O--CH.sub.2 --CHOH--CH.sub.2 --O--CO--R.sup.2,in which R.sup. 1 --CO--is a residue of a monobasic carboxylic acid having 8 to 18 carbon atoms in a molecule, e.g., lauric acid, and R.sup.2 is a residue of a polybasic carboxylic acid, e.g., succinic acid, from which one of the carboxyl groups is eliminated of which is a 1% by weight aqueous solution has a pH value in the range from 4 to 10 at 25.degree. C. The dentifrice composition compounded with 0.1-10% by weight of the above defined foaming agent has outstandingly high foamability and is advantageous in respect of the little adverse influences on the stability of enzymes contained in the dentrifrices composition.

Abstract: This invention provides a detergent composition by which proteinaceous depositions can be easily removed from contact lenses in a short time, and a method for removing such depositions from the contact lenses. The detergent composition comprises an anionic or amidoamine-type ampholytic surfactant; and thiourea or a reductant.